New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations

Author： Mutlu N. Başşaran   Değğim Zelihagüül   Yıılmaz ŞŞüükran   Eşşsiz Dinçç   Nacar Ahmet  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.37, Iss.7, 2011-07, pp. : 775-789

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

By Yang Lily P.H.   Keating Gillian M.  

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 957-965

Adis International

Access to resources Recommend Favorite

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine

By Brett Hauber A.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine

By Linkins K.W.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 609-612

Adis International

Access to resources Recommend Favorite

New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases

By Réeff Jonathan   Gaignaux Amelie   Goole Jonathan   De Vriese Carine   Amighi Karim  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 11, 2013-11 ,pp. : 1731-1741

Informa Healthcare

Access to resources Recommend Favorite

Liposomal formulations for inhalation

By Cipolla David   Gonda Igor   Chan Hak-Kim  

Therapeutic Delivery, Vol. 4, Iss. 8, 2013-08 ,pp. : 1047-1072

Future Science

Access to resources Recommend Favorite